✦ LIBER ✦

66 Rifaximin Reduces the Risk of Hospitalizations in Patients with Previous Episodes of Hepatic Encephalopathy: Results from a Phase 3 Placebo-Controlled Trial

✍ Scribed by Guy Neff; Carroll B. Leevy; Todd Frederick; Kunal Merchant; Shirley Huang; Audrey L. Shaw; William P. Forbes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

207 SAFETY OF RIFAXIMIN IN PATIENTS WITH

✍ K. Mullen; S. Sigal; M. Sheikh; N. Bass; F. Poordad; K. Merchant; S. Huang; A. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

15 RIFAXIMIN TREATMENT IMPROVED QUALITY

✍ A. Sanyal; N. Bass; K. Mullen; F. Poordad; A. Shaw; K. Merchant; E. Bortey; W.P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Rifaximin Improves Cognitive Functions a

✍ Sidhu, Sandeep; Goyal, Omesh; Mishra, Bholeshwar P.; Sood, Ajit; Chhina, Rajoo S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 111 KB

1043 PENTOXIFYLLINE (PTX) REDUCES THE RI

✍ Lebrec, D.; Thabut, D.; Oberti, F.; Perarnau, J.-M.; Condat, B.; Barraud, H.; Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Results from CONNECTION: A global, Phase

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Adalimumab treatment is associated with

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 79 KB